Prognostic impact of recurrent laryngeal nerve lymph node metastatic status in thoracic esophageal squamous cell carcinoma
Diseases of the Esophagus · 2025
DOI: 10.1093/dote/doaf052 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diseases of the Esophagus, 2025. Verfasst von Pengjie Yang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Oncology Surgery, Inner Mongolia Hospital of Peking University Cancer Hospital (Affiliated Cancer Hospital of Inner Mongolia M…. Hauptthemen laut MEDLINE: Esophageal Neoplasms, Esophageal Squamous Cell Carcinoma, Recurrent Laryngeal Nerve, Lymphatic Metastasis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 17 Literaturangaben.
Abstract (Originalsprache)
Esophageal squamous cell carcinoma (ESCC) is a highly aggressive malignancy with poor prognosis, and lymph node metastasis significantly influences patient outcomes. This retrospective study analyzed 189 thoracic ESCC patients who underwent radical esophagectomy (2019–2021) to evaluate the prognostic role of recurrent laryngeal nerve lymph node metastasis (RLN LNM). Patients with RLN LNM showed significantly worse overall survival (OS, P = 0.01) and disease-free survival (DFS, P = 0.046) than those without metastasis, with a 50.53% higher mortality risk and 37.83% higher recurrence risk. Subgroup analysis revealed no survival differences between left- and right-sided RLN LNM (P>0.05), while bilateral RLN LNM trended toward poorer outcomes but without statistical significance. Patients with RLN LNM plus extranodal metastases had markedly reduced OS (P = 0.0014) and DFS (P = 0.0008) compared to isolated RLN LNM. RLN LNM significantly predicted poor prognosis in lower thoracic ESCC (OS: P = 0.0027; DFS: P = 0.037) but not in upper or middle thoracic tumors. Multivariate Cox regression identified RLN LNM, perineural invasion, lymphovascular invasion, and neoadjuvant chemoradiotherapy with immunotherapy as independent risk factors for OS. These findings highlight RLN LNM as a critical prognostic indicator, particularly for lower thoracic ESCC, and emphasize the importance of integrating RLN LNM status into treatment strategies and staging systems.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Thoracic Oncology Surgery, Inner Mongolia Hospital of Peking University Cancer Hospital (Affiliated Cancer Hospital of Inner Mongolia Medical University), Hohhot, Inner Mongolia Autonomous Region, China.
- Department of Thoracic Surgery, The Ninth Hospital of Xingtai City, Hebei 054000, China.
- Endoscopy Center, Inner Mongolia Hospital of Peking University Cancer Hospital (Affiliated Cancer Hospital of Inner Mongolia Medical University), Hohhot, Inner Mongolia Autonomous Region 010050, China.
- Department of Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
- College of Pharmacy, Inner Mongolia Medical University, Hohhot, Inner Mongolia Autonomous Region 010110, China.
- Department of Cardio-Thoracic Surgery, The Second Hospital of Chifeng, Chifeng City, Inner Mongolia Autonomous Region 024000, China.
Zitieren
APA
Yang, P., Xue, B., Liu, T., Qi, L., Guo, Q., Yang, T., Sun, M., Yu, Y., Han, B., & Li, Y. (2025). Prognostic impact of recurrent laryngeal nerve lymph node metastatic status in thoracic esophageal squamous cell carcinoma. Diseases of the Esophagus. https://doi.org/10.1093/dote/doaf052
Vancouver
Yang P, Xue B, Liu T, Qi L, Guo Q, Yang T, et al. Prognostic impact of recurrent laryngeal nerve lymph node metastatic status in thoracic esophageal squamous cell carcinoma. Diseases of the Esophagus. 2025. doi:10.1093/dote/doaf052
BibTeX
@article{Yang2025,
author = {Yang, Pengjie and Xue, Bing and Liu, Tianlai and Qi, Lin and Guo, Qiang and Yang, Ting and Sun, Mengfei and Yu, Yongjun and Han, Bater and Li, Yong},
title = {Prognostic impact of recurrent laryngeal nerve lymph node metastatic status in thoracic esophageal squamous cell carcinoma},
journal = {Diseases of the Esophagus},
year = {2025},
doi = {10.1093/dote/doaf052}
}
EUVIMED